Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) - Global Forecast to 2032

Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) - Global Forecast to 2032

Global Automated Breast Ultrasound Systems (ABUS) Market size will expand exponentially through 2032. Favorable reimbursement policies for breast ultrasound and digital breast tomosynthesis in the U.S. is paving the path for industry growth. Under the Affordable Care Act, the American Cancer Society Cancer Action Network offers comprehensive coverage for breast cancer screening. It also encourages states to increase their healthcare coverage for people from low-income groups through the state Medicaid programs.

Moreover, the limited capability of mammography in analyzing dense breast tissues has further increased the adoption of automated breast ultrasound systems. ABUS provides clearer and more detailed images, enhancing the visualization and characterization of cancerous lesions. This results in accurate and timely diagnosis and helps reduce false negatives by detecting cancers that may not have detected through mammography.
The overall automated breast ultrasound systems market is segmented based on product, end-use, and region.
Based on the product, the automated breast volume scanner (ABVS) market share will grow at more than 15% CAGR from 2023 to 2032. Recent advancements in ABVS are presenting lucrative opportunities for segment expansion. Some ABVS systems now incorporate AR visualization technology, allowing radiologists to view and interact with the 3D images in a virtual environment. AR technology provides a more intuitive and immersive experience, enhancing the radiologist's ability to interpret the images for better patient outcomes.

Based on end-use, automated breast ultrasound systems market value from the diagnostic imaging centers segment will amass lucrative gains over 2023-2032. Growing healthcare expenditure in developing economies such as India and China has increased the number of diagnostic imaging centers, creating a notable impetus for segment growth. Moreover, these facilities have high availability of specialized diagnostic tools, which has made them a preferred healthcare provider.
These centers also offer a range of imaging modalities, allowing for a multi-modal approach to breast cancer detection. Combining multiple imaging techniques, such as mammography, ultrasound, and MRI, enhances the accuracy and sensitivity of detection, further driving product demand.

On the regional front, Europe automated breast ultrasound systems market will be worth USD 1.2 billion by 2032. Rising prevalence of breast cancer attributed to the growing adoption of a sedentary lifestyle and inadequate eating habits has increased product uptake in the region. Moreover, industry players in the region, such as Koninklijke Philips N.V. and others, are investing in product innovations to broaden their customer base, thus, creating a favorable growth outlook for the regional ABUS industry.